Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter updated to Revision: v3.4.2. The prior government funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page update mainly adds a government funding notice and a new version label (v3.4.1), which are global site notices and do not modify study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page adds a glossary display toggle and new metadata lines such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removes 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was published, replacing the prior Revision: v3.3.3. No changes to the study details or core content are apparent.SummaryDifference0.1%

- Check64 days agoChange DetectedBeijing Municipality is added as a study location under Locations. The page's previous combined Beijing Municipality Locations grouping is removed and the HHS Vulnerability Disclosure link is removed; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page shows a revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.